Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-022759

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shahbazi Hamed · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-09 Grant or award : show line 1 in the form Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/wf-form4_166035310008029.xml…